- Home
- BTAI vs FLNT Comparison
BTAI vs FLNT Comparison
Compare BTAI & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- FLNT
- Stock Information
- Founded
- BTAI 2017
- FLNT 2001
- Country
- BTAI United States
- FLNT United States
- Employees
- BTAI N/A
- FLNT N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- FLNT Advertising
- Sector
- BTAI Health Care
- FLNT Consumer Discretionary
- Exchange
- BTAI Nasdaq
- FLNT Nasdaq
- Market Cap
- BTAI 52.7M
- FLNT 53.4M
- IPO Year
- BTAI 2018
- FLNT N/A
- Fundamental
- Price
- BTAI $3.79
- FLNT $2.19
- Analyst Decision
- BTAI Strong Buy
- FLNT Hold
- Analyst Count
- BTAI 4
- FLNT 1
- Target Price
- BTAI $40.00
- FLNT $3.00
- AVG Volume (30 Days)
- BTAI 14.1M
- FLNT 2.1M
- Earning Date
- BTAI 08-12-2025
- FLNT 08-19-2025
- Dividend Yield
- BTAI N/A
- FLNT N/A
- EPS Growth
- BTAI N/A
- FLNT N/A
- EPS
- BTAI N/A
- FLNT N/A
- Revenue
- BTAI $868,000.00
- FLNT $229,839,000.00
- Revenue This Year
- BTAI N/A
- FLNT N/A
- Revenue Next Year
- BTAI $597.46
- FLNT $2.01
- P/E Ratio
- BTAI N/A
- FLNT N/A
- Revenue Growth
- BTAI N/A
- FLNT N/A
- 52 Week Low
- BTAI $1.17
- FLNT $1.50
- 52 Week High
- BTAI $13.36
- FLNT $3.83
- Technical
- Relative Strength Index (RSI)
- BTAI 48.02
- FLNT 49.05
- Support Level
- BTAI $3.41
- FLNT $2.08
- Resistance Level
- BTAI $4.20
- FLNT $2.27
- Average True Range (ATR)
- BTAI 0.62
- FLNT 0.30
- MACD
- BTAI -0.27
- FLNT -0.00
- Stochastic Oscillator
- BTAI 11.05
- FLNT 39.84
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.